Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 38,309 | 35,954 | 36,365 | 30,205 | 31,014 |
| Cost of Goods | 7,348 | 5,310 | 4,545 | 4,681 | 4,869 |
| Gross Profit | 30,961 | 30,644 | 31,820 | 25,524 | 26,145 |
| Operating Expenses | 18,567 | 16,950 | 16,527 | 16,404 | 18,397 |
| Operating Income | 12,742 | 14,004 | 15,838 | 9,801 | 8,617 |
| Other Income | 71 | 68 | 62 | 81 | 107 |
| Pre-tax Income | 12,813 | 14,072 | 15,900 | 9,882 | 8,724 |
| Income Tax | 3,504 | 3,743 | 3,719 | 2,219 | -2,713 |
| Net Income Continuous | 9,309 | 10,329 | 12,181 | 7,663 | 11,437 |
| Net Income | $9,309 | $10,329 | $12,181 | $7,663 | $11,437 |
| EPS Basic Total Ops | 0.09 | 0.10 | 0.12 | 0.07 | 0.11 |
| EPS Basic Continuous Ops | 0.09 | 0.10 | 0.12 | 0.07 | 0.11 |
| EPS Diluted Total Ops | 0.09 | 0.10 | 0.11 | 0.07 | 0.11 |
| EPS Diluted Continuous Ops | 0.09 | 0.10 | 0.11 | 0.07 | 0.11 |
| EBITDA(a) | $12,775 | $14,035 | $15,869 | $9,898 | $8,636 |